An interventional study of Kinesio Taping and Standard Conservative Treatment in Lipedema, sponsored by Hatice Zehra FERHATLAR. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Hatice Zehra FERHATLAR · Not applicable, Interventional, and Treatment
This prospective, randomized controlled trial aims to evaluate the effectiveness of kinesio taping as an adjunct to standard conservative treatment in women with stage II lower-extremity lipedema.
A total of 30 women will be randomly assigned to two groups: a control group receiving standard conservative treatment and an intervention group receiving kinesio taping in addition to standard conservative treatment. Both groups will receive patient education, physical activity recommendations, and a standardized home exercise program. The intervention group will additionally receive bilateral lower-extremity kinesio taping twice weekly for six weeks.
Participants will be assessed at baseline, week 6 (end of treatment), and week 10 (four-week follow-up). The primary outcome will be the change in pain intensity measured using the Visual Analog Scale (VAS) at week 6. Secondary outcomes will include lower-extremity functional status (LEFS), quality of life (EQ-5D-3L), walking performance (4-meter walk test), lower-extremity circumference measurements, and pressure pain threshold assessed using an algometer.
The study aims to determine whether adding kinesio taping to standard conservative treatment provides additional clinical benefits in women with lipedema.
85 studies on the registry are indexed under Lipedema; 32 are open to participants now.
This study's planned enrollment of 30 is below the median of 35 across 42 interventional studies indexed under Lipedema.
Browse Lipedema studies →Hatice Zehra FERHATLAR is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
**Inclusion Criteria:**
**Exclusion Criteria:**
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Kinesio Taping · Behavioral: Standard Conservative Treatment
Behavioral: Standard Conservative Treatment
Kinesio taping will be applied bilaterally to the lower extremities of participants in the experimental group twice weekly for six weeks, for a total of 12 applications. Kinesio taping will be administered in addition to standard conservative treatment.
Standard conservative treatment will consist of patient education regarding lipedema and symptom management, physical activity recommendations, and a standardized lower-extremity home exercise program. This treatment will be provided to participants in both groups during the six-week intervention period.
Change in Pain Intensity Measured by the Visual Analog Scale (VAS)
Time frame: Baseline (week 0), week 6, and week 10
Change in Lower Extremity Functional Scale (LEFS) Score
Time frame: Baseline (week 0), week 6, and week 10
Change in Health-Related Quality of Life Measured by EQ-5D-3L
Time frame: Baseline (week 0), week 6, and week 10
Change in Walking Performance Assessed by the 4-Meter Walk Test
Time frame: Baseline (week 0), week 6, and week 10
Change in Lower Extremity Circumference Measurements
Time frame: Baseline (week 0), week 6, and week 10
Change in Pressure Pain Threshold (PPT) Measured by Algometry
Time frame: Baseline (week 0), week 6, and week 10
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Jan 2027, 4 months after the start.
Of 29 interventional studies with no phase under Lipedema, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 4 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hatice Zehra FERHATLAR